Vycor Medical (VYCO) Restructuring Costs (2012)

Vycor Medical's (VYCO) quarterly Restructuring Costs came in at $18285.0 in Q1 2012.

Vycor Medical (VYCO) Restructuring Costs (2012) Analysis & Trends

Vycor Medical (VYCO) has 1 years of Restructuring Costs data on file, last reported at $18285.0 in Q1 2012.

On a quarterly basis, Restructuring Costs changed N/A year-over-year to $18285.0 in Q1 2012; TTM through Dec 2012 was $18285.0, a N/A change from a year earlier, with the FY2012 full-year figure at $18285.0, down 83.38% from the prior year.
Restructuring Costs for Q1 2012 stood at $18285.0.
Over the last five years, Restructuring Costs for VYCO reached as high as $18285.0 in Q1 2012 and fell as low as $18285.0 in Q1 2012.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Vycor Medical	2.34 Mn	2.16 Mn	375,153.00

Historic Data

Download Data

Date	Value
Mar 31, 2012	18,285.00